Proprietary AI analyst is now available

Procter & Gamble Hygiene Valuation Multiples

Discover revenue and EBITDA valuation multiples for Procter & Gamble Hygiene and similar public comparables like Rohto Pharmaceutical, e.l.f. Beauty, Unilever Indonesia, Inter Parfums and more.

Procter & Gamble Hygiene Overview

About Procter & Gamble Hygiene

Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.


Founded

1964

HQ

India

Employees

421

Website

in.pg.com

Financials (LTM)

Revenue: $462M
EBITDA: $125M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Procter & Gamble Hygiene Financials

Procter & Gamble Hygiene reported last 12-month revenue of $462M and EBITDA of $125M.

In the same LTM period, Procter & Gamble Hygiene generated $125M in EBITDA and $92M in net income.

Revenue (LTM)


Procter & Gamble Hygiene P&L

In the most recent fiscal year, Procter & Gamble Hygiene reported revenue of $455M and EBITDA of $126M.

Procter & Gamble Hygiene is profitable as of last fiscal year, with gross margin of 62%, EBITDA margin of 28%, and net margin of 20%.

See analyst estimates for Procter & Gamble Hygiene
LTMLast FY202320242025202620272028
Revenue$462M$455M$428M$372M$421M
Gross Profit-$282M$236M$211M$262M
Gross Margin-62%55%57%62%
EBITDA$125M$126M$103M$97M$118M
EBITDA Margin27%28%24%26%28%
EBIT Margin27%27%22%25%26%
Net Profit$92M$90M$70M$67M$83M
Net Margin20%20%16%18%20%

Financial data powered by Morningstar, Inc.

Procter & Gamble Hygiene Stock Performance

Procter & Gamble Hygiene has current market cap of $3B, and enterprise value of $3B.

Market Cap Evolution


Procter & Gamble Hygiene's stock price is $98.27.

Procter & Gamble Hygiene share price decreased by 3.3% in the last 30 days, and by 32.1% in the last year.

Procter & Gamble Hygiene has an EPS (earnings per share) of $2.79.

See more trading valuation data for Procter & Gamble Hygiene
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$3B0.7%-3.3%-1.6%-32.1%$2.79

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Procter & Gamble Hygiene Valuation Multiples

Procter & Gamble Hygiene trades at 6.8x EV/Revenue multiple, and 25.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Procter & Gamble Hygiene

EV / Revenue (LTM)


Procter & Gamble Hygiene Financial Valuation Multiples

As of June 5, 2026, Procter & Gamble Hygiene has market cap of $3B and EV of $3B.

Procter & Gamble Hygiene has a P/E ratio of 34.8x.

LTMLast FY202320242025202620272028
EV/Revenue6.8x6.9x7.3x8.4x7.4x
EV/EBITDA25.0x24.8x30.2x32.1x26.4x
EV/EBIT25.1x25.5x32.8x34.3x28.3x
EV/Gross Profit-11.1x13.2x14.8x11.9x
P/E34.8x35.3x45.4x47.5x38.3x
EV/FCF34.2x33.5x58.4x58.9x38.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Procter & Gamble Hygiene Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Procter & Gamble Hygiene Margins & Growth Rates

Procter & Gamble Hygiene grew revenue by 8% and EBITDA by 4% in the last fiscal year.

In the most recent fiscal year, Procter & Gamble Hygiene reported gross margin of 62%, EBITDA margin of 28%, and net margin of 20%.

See estimated margins and future growth rates for Procter & Gamble Hygiene

Procter & Gamble Hygiene Margins

Last FY202420252026202720282029
Gross Margin62%57%62%59%
EBITDA Margin28%26%28%27%
EBIT Margin27%25%26%27%
Net Margin20%18%20%20%
FCF Margin21%14%20%18%

Procter & Gamble Hygiene Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%(13%)13%14%
Gross Profit Growth-(10%)24%8%
EBITDA Growth4%(6%)21%10%
EBIT Growth9%(4%)21%17%
Net Profit Growth8%(4%)24%14%
FCF Growth(11%)(1%)55%4%

Data powered by FactSet, Inc. and Morningstar, Inc.

Procter & Gamble Hygiene Operational KPIs

Procter & Gamble Hygiene's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.4M for the same period.

Procter & Gamble Hygiene's Rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Procter & Gamble Hygiene's Rule of X is 62% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Procter & Gamble Hygiene
LTMLast FY202320242025202620272028
Rule of 4035%41%---
Bessemer Rule of X46%62%---
Revenue per Employee-$1.1M---
Opex per Employee-$0.4M---
S&M Expenses to Revenue-12%14%15%13%
G&A Expenses to Revenue--1%1%0%
Opex to Revenue-36%33%32%36%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Procter & Gamble Hygiene Competitors

Procter & Gamble Hygiene competitors include Rohto Pharmaceutical, e.l.f. Beauty, Unilever Indonesia, Inter Parfums, Hengan Group, Lion Corp., Giant Biogene, Natura Cosmeticos, Gillette India and Bic.

Most Procter & Gamble Hygiene public comparables operate across Health & Beauty.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Rohto Pharmaceutical1.6x1.4x8.9x8.5x
e.l.f. Beauty2.3x2.2x11.0x10.7x
Unilever Indonesia1.6x1.7x10.5x10.4x
Inter Parfums1.9x1.9x9.2x9.5x
Hengan Group1.0x1.0x5.3x5.8x
Lion Corp.0.9x0.9x6.9x6.9x
Giant Biogene3.1x3.0x6.9x7.4x
Natura Cosmeticos0.8x0.8x6.9x6.3x

This data is available for Pro users. Sign up to see all Procter & Gamble Hygiene competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Procter & Gamble Hygiene

When was Procter & Gamble Hygiene founded?Procter & Gamble Hygiene was founded in 1964.
Where is Procter & Gamble Hygiene headquartered?Procter & Gamble Hygiene is headquartered in India.
How many employees does Procter & Gamble Hygiene have?As of today, Procter & Gamble Hygiene has over 421 employees.
Is Procter & Gamble Hygiene publicly listed?Yes, Procter & Gamble Hygiene is a public company listed on National Stock Exchange of India.
What is the stock symbol of Procter & Gamble Hygiene?Procter & Gamble Hygiene trades under PGHH ticker.
When did Procter & Gamble Hygiene go public?Procter & Gamble Hygiene went public in 2004.
Who are competitors of Procter & Gamble Hygiene?Procter & Gamble Hygiene main competitors include Rohto Pharmaceutical, e.l.f. Beauty, Unilever Indonesia, Inter Parfums, Hengan Group, Lion Corp., Giant Biogene, Natura Cosmeticos, Gillette India, Bic.
What is the current market cap of Procter & Gamble Hygiene?Procter & Gamble Hygiene's current market cap is $3B.
What is the current revenue of Procter & Gamble Hygiene?Procter & Gamble Hygiene's last 12 months revenue is $462M.
What is the current revenue growth of Procter & Gamble Hygiene?Procter & Gamble Hygiene revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Procter & Gamble Hygiene?Current revenue multiple of Procter & Gamble Hygiene is 6.8x.
What is the current EBITDA of Procter & Gamble Hygiene?Procter & Gamble Hygiene's last 12 months EBITDA is $125M.
What is Procter & Gamble Hygiene's EBITDA margin?Procter & Gamble Hygiene's last 12 months EBITDA margin is 27%.
What is the current EV/EBITDA multiple of Procter & Gamble Hygiene?Current EBITDA multiple of Procter & Gamble Hygiene is 25.0x.
What is the current FCF of Procter & Gamble Hygiene?Procter & Gamble Hygiene's last 12 months FCF is $91M.
What is Procter & Gamble Hygiene's FCF margin?Procter & Gamble Hygiene's last 12 months FCF margin is 20%.
What is the current EV/FCF multiple of Procter & Gamble Hygiene?Current FCF multiple of Procter & Gamble Hygiene is 34.2x.
How many companies Procter & Gamble Hygiene has acquired to date?Procter & Gamble Hygiene hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Procter & Gamble Hygiene has invested to date?Procter & Gamble Hygiene hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Procter & Gamble Hygiene

Lists including Procter & Gamble Hygiene

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial